Nevro Corp.
US ˙ NYSE ˙ US64157F1030
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityNVRO / Nevro Corp.
InstitutionStrs Ohio
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Strs Ohio closes position in NVRO / Nevro Corp.

On August 4, 2025 - Strs Ohio filed a 13F-HR form disclosing ownership of 0 shares of Nevro Corp. (US:NVRO) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 28, 2025 disclosing 2,700 shares of Nevro Corp.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-04 2025-06-30 13F NEVRO COM_STK 64157F103 0 -100.00 0
2025-05-28 2025-03-31 13F NEVRO COM_STK 64157F103 2,700 2,700 16 0.0001
2022-10-27 2022-09-30 13F NEVRO COM 64157F103 0 -5,100 -100.00 0 -100.00
2022-07-25 2022-06-30 13F NEVRO COM 64157F103 5,100 300 6.25 223 -35.73 0.0010
2022-04-21 2022-03-31 13F NEVRO COM 64157F103 4,800 0 0.00 347 -10.80 0.0013
2022-01-24 2021-12-31 13F NEVRO COM 64157F103 4,800 0 0.00 389 -30.29 0.0014
2021-10-22 2021-09-30 13F NEVRO COM 64157F103 4,800 -100 -2.04 558 -31.28 0.0021
2021-07-26 2021-06-30 13F NEVRO COM 64157F103 4,900 1,400 40.00 812 66.39 0.0029
2021-04-23 2021-03-31 13F NEVRO COM 64157F103 3,500 -4,700 -57.32 488 -65.61 0.0018
2021-01-25 2020-12-31 13F NEVRO COM 64157F103 8,200 -3,500 -29.91 1,419 -12.89 0.0055
2020-12-14 2020-09-30 13F NEVRO COM 64157F103 11,700 -400 -3.31 1,629 12.73 0.0068
2020-07-23 2020-06-30 13F NEVRO COM 64157F103 12,100 200 1.68 1,445 21.53 0.0063
2020-04-23 2020-03-31 13F NEVRO COM 64157F103 11,900 -700 -5.56 1,189 -19.72 0.0063
2020-01-24 2019-12-31 13F NEVRO COM 64157F103 12,600 9,200 270.59 1,481 407.19 0.0062
2019-10-21 2019-09-30 13F/A-1 NEVRO COM 64157F103 3,400 -3,529 -50.93 292 -34.97 0.0013
2019-10-21 2019-09-30 13F NEVRO COM 64157F103 3,400 -9,200 292 1,292.4082
2019-07-25 2019-06-30 13F NEVRO COM 64157F103 6,929 0 0.00 449 3.70 0.0020
2019-04-19 2019-03-31 13F NEVRO COM 64157F103 6,929 0 0.00 433 60.97 0.0020
2019-01-23 2018-12-31 13F NEVRO COM 64157F103 6,929 0 0.00 269 -31.73 0.0014
2018-10-19 2018-09-30 13F NEVRO COM 64157F103 6,929 -800 -10.35 394 -36.14 0.0017
2018-08-06 2018-06-30 13F NEVRO COM 64157F103 7,729 0 0.00 617 -7.77 0.0027
2018-04-20 2018-03-31 13F NEVRO COM 64157F103 7,729 800 11.55 669 39.96 0.0030
2018-01-23 2017-12-31 13F NEVRO COM 64157F103 6,929 -1,400 -16.81 478 -36.77 0.0020
2017-10-23 2017-09-30 13F NEVRO COM 64157F103 8,329 7,929 1,982.25 756 2,506.90 0.0032
2017-07-26 2017-06-30 13F NEVRO COM 64157F103 400 -700 -63.64 29 -71.84 0.0001
2017-04-26 2017-03-31 13F NEVRO COM 64157F103 1,100 -4,695 -81.02 103 -75.53 0.0004
2017-01-24 2016-12-31 13F NEVRO COM 64157F103 5,795 3,495 151.96 421 75.42 0.0019
2016-10-27 2016-09-30 13F NEVRO COM 64157F103 2,300 2,000 666.67 240 990.91 0.0011
2016-07-26 2016-06-30 13F NEVRO COM 64157F103 300 -4,533 -93.79 22 -91.88 0.0001
2016-04-25 2016-03-31 13F/A-1 NEVRO COM 64157F103 4,833 -1,600 -24.87 271 -37.56 0.0012
2016-04-21 2016-03-31 13F NEVRO COM 64157F103 4,833 271
2016-01-28 2015-12-31 13F NEVRO COM 64157F103 6,433 6,433 0.00 434 0.0019
2015-04-27 2015-03-31 13F/A-1 NEVRO COM 64157F103 0 -2,800 -100.00 0 -100.00
2015-01-23 2014-12-31 13F NEVRO COM 64157F103 2,800 2,800 108 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.